Victoria is a Principal at aMoon Velocity, where she is involved in the scientific and commercial evaluation of investment opportunities. Once a company joins aMoon's portfolio, she supports the management team in all the stages of company formation: including recruitment of talent for the company and boards, product and business development and strategy definition.
Given that aMoon invests in companies that have a real potential to accelerate cure, Victoria is keen on being able to take part in identifying these companies and helping them provide new solutions to healthcare’s greatest cost drivers.
Victoria is a multidisciplinary biomedical professional with extensive expertise in healthcare innovation. She is a scientist by training with more than 20 years of experience in research and business development, first in academia and then in pharma industry.
Prior to joining aMoon, Victoria worked as a Director of Business Development in BiolineRX, where she performed global scouting and led scientific and commercial evaluation of novel therapeutics. Previously Victoria worked as a Research Scientist for Amazon and as a Drug Development Manager for Influmedix.
Victoria conducted her Postdoctoral Research at the department of Neurobiology at Northwestern University and earned her PhD in Neuroscience from the Hebrew University School of Medicine.